BSCL2 and breast carcinoma: To ensure the lack of differences in lipid synthesis was not due to residual seipin, we deleted seipin in human mammary carcinoma cells (SUM159) by CRISPR/Cas9-mediated genome editing (Ran et al., 2013) (Figure 1—figure supplement 1C).